Skip to main content
SpringerLink
Log in

ASO Author Reflections: BRCA Mutation Status for Personalizing Management of Recurrent Ovarian Cancer—A Multicenter Study

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Du Bois A, Vergote I, Ferron G, et al. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. J Clin Oncol. 2017;35(Suppl; abstr 5501).

    Article  Google Scholar 

  2. Coleman R, Enserro D, Spirtos N, et al. A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): a NRG Oncology/Gynecologic Oncology Group (GOG) study. J Clin Oncol. 2018;36 (suppl; abstr 5501).

    Article  Google Scholar 

  3. Gallagher DJ, Konner JA, Bell-McGuinn KM, et al. Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol. 2011;22:1127–1132.

    Article  CAS  Google Scholar 

  4. Bookman MA, Tyczynski JE, Espirito JL,Wilson TW, Fernandes AW. Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer. Gynecol Oncol. 2017;146:58–63.

    Article  CAS  Google Scholar 

  5. Marchetti C, De Leo R, Musella A, et al. BRCA mutation status to personalize management of recurrent ovarian cancer: a multicenter study. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-6700-6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fondazione Policlinico Universitario A. Gemellli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

    Anna Fagotti MD, PhD

Authors
  1. Anna Fagotti MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Fagotti MD, PhD.

Ethics declarations

Disclosure

There are no conflicts of interests.

Additional information

ASO Author Reflections offer a brief invited commentary on the article, BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-6700-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fagotti, A. ASO Author Reflections: BRCA Mutation Status for Personalizing Management of Recurrent Ovarian Cancer—A Multicenter Study. Ann Surg Oncol 25, 3709–3710 (2018). https://doi.org/10.1245/s10434-018-6724-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6724-y

Keywords

Search

Navigation